Table 1 Characteristics of the conversion therapy group and the palliative chemotherapy group

Gender

0.321

 Male

7

11

 Female

11

9

Median age

49.8(28 ~ 72)

53.5(35 ~ 73)

0.185

 Upper

1

4

 Middle

11

10

 Lower

6

6

0.417

Differentiation

0.758

 Well and moderately

9

11

 Poorly

9

9

Initial DSL

0.321

 PCI < 10

11

9

 PCI ≥ 10

7

11

Second DSL

<0.001

 PCI < 6

18

2

 PCI ≥ 6

0

18

Ascites

0.516

 Positive

8

11

 Negative

10

9

Serum CEA (ng/ml)

0.544

 Normal

15

18

 >5

3

2

Serum CA19–9 (U/ml)

0.914

 Normal

12

13

 >39

6

7

Serum CA125 (U/ml)

0.703

 Normal

7

9

 >35

11

11

 Normal

12

15

0.532

 >7

6

5